Discover
Turning new ideas into molecules that positively impact human health
Our pipeline
Target
(Disease) Disease
(Disease) Disease
Discovery
Preclinical
Clinical
FXR
Agonists
Licensed to Intercept Pharmaceuticals
Metabolic
ACMSD
Inhibitors
Metabolic
NR2F6
Antagonists
Cancer
LRH-1
Inverse agonists
Partnered with Sterling
Cancer